Related Experiment Video
Updated: Mar 13, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Multiple machine-learning-driven metabolic frameworks for long-term prognostic risk assessment in patients with
Qiong Xu1, Yanan Xu2,3, Yijun Wang4
1Department of Cardiology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Background:
Predictive obesity indices are often based on the body mass index (BMI). Although BMI is widely used, it does not provide a direct measure of obesity. We aimed to utilize multiple machine learning-driven metabolic frameworks to investigate the long-term risk of major adverse cardiovascular and cerebrovascular events (MACCEs) in individuals with hypertension and obstructive sleep apnea (OSA).
Methods:
This study included 708 patients with hypertension and OSA between January 2017 and December 2021. The measurements of height, weight, neck circumference (NC), waist circumference (WC), neck-circumference-to-height ratio (NHtR), and waist-to-height ratio (WHtR) were collected to calculate the triglyceride-glucose (TyG)-BMI, as well as TyG-NC, TyG-WC, TyG-NHtR, and TyG-WHtR indices.
Results:
All patients were allocated to the training cohort (n = 446) and independent validation cohort (n = 262). The Boruta plot presented for identifying key predictors is as follows: male sex, age, TyG, TyG-BMI, HbA1c, FPG, triglyceride, creatinine, fibrinogen and AHI. We constructed nine machine learning models-XGBoost, Light Gradient Boosting Machine, Random Forest, Decision Tree, Gradient Boosting, Multi-Layer Perceptron, Support Vector Machine, K-Nearest Neighbors, and Gaussian Naive Bayes-to predict MACCEs. The XGBoost model was selected due to its superior performance evidenced by an AUC of 0.898 (95% CI: 0.822-0.973) and net clinical benefit. SHAP analysis further clarified variable contributions to MACCE risk.
Conclusion:
This study employed various machine-learning techniques and multidimensional data assessment, allowing for enhanced prediction of metabolic results and supporting the timely detection of high-risk patients with OSA and hypertension in need of focused preventive measures.
Clinical Trial Registration:
https://www.chictr.org.cn/bin/project/edit?pid=206415, identifier ChiCTR2300075727.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Pre-Procedural Guidelines for Assessing Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Heart Failure VI: Adjunct Therapies

